Find clinical trials for Endometrial Cancer in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Seattle, WA, USA:
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...
Phase 2
Seattle, Washington, United States and 7 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Seattle, Washington, United States and 202 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Seattle, Washington, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Seattle, Washington, United States and 75 other locations
This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...
Phase 1, Phase 2
Seattle, Washington, United States and 17 other locations
Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.
Phase 1
Seattle, Washington, United States and 6 other locations
to other places in the body, it is called advanced or metastatic cancer. Participants in this study must have head and neck squamous cell ca ...
Phase 2
Seattle, Washington, United States and 26 other locations
in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...
Phase 1, Phase 2
Seattle, Washington, United States and 67 other locations
The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...
Phase 2
Tacoma, Washington, United States and 79 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...
Phase 1, Phase 2
Seattle, Washington, United States and 50 other locations
Clinical trials
Research sites
Resources
Legal